External cephalic version offers expectant parents a non-surgical path forward when their baby settles into a breech position near the end of pregnancy, using gentle pressure and medical expertise to encourage the baby into a head-down position for a safer delivery.

Helping Babies Find Their Way: What External Cephalic Version Aims to Achieve

When pregnancy reaches its final weeks, most babies naturally shift into a head-down position, preparing for birth. However, in about 3 to 4 out of every 100 full-term pregnancies, babies remain in a breech position—meaning their feet or bottom are pointing downward instead of their head. This situation presents challenges for vaginal delivery and often leads to the need for cesarean section surgery. External cephalic version, often called ECV, is a medical procedure designed to address this situation without requiring surgery.^[1]

The primary goal of external cephalic version is to increase the chances of a vaginal birth by manually rotating the baby from a breech or sideways position into a head-down position. This procedure works by applying controlled, firm pressure on the mother’s abdomen from the outside, guiding the baby into the optimal position for delivery. The approach is particularly valuable because it offers an alternative to cesarean delivery, which is considered abdominal surgery with its own recovery period and risks.^[2]

Healthcare providers typically recommend ECV around 37 weeks of pregnancy, although some may begin discussions as early as 36 weeks. By this stage, if a baby hasn’t turned on its own, it’s unlikely to do so spontaneously. At the same time, there’s still enough amniotic fluid surrounding the baby to allow movement during the procedure. Waiting until this point also means that if any complications arise requiring immediate delivery, the baby is mature enough to be born safely.^[3]

The importance of this procedure extends beyond individual births. Fetal malpresentation—when the baby is not in the ideal head-down position—ranks as the third most common reason for cesarean deliveries globally, accounting for nearly 17 percent of all cesarean sections. With cesarean section rates reaching 34 percent worldwide, efforts to safely reduce unnecessary surgical deliveries have become a priority in maternal healthcare. Routine use of external cephalic version could potentially reduce the cesarean delivery rate by about two-thirds for breech presentations, making it a significant tool in modern obstetric practice.^[4]

Standard Approach to External Cephalic Version

External cephalic version follows a well-established protocol that has been refined over decades of clinical practice. The procedure is always performed in a hospital setting, specifically near an operating room equipped for emergency cesarean delivery. This location is crucial because, although rare, complications can occur that require immediate surgical intervention. The entire process typically takes about two hours when including all the preparation, monitoring before the procedure, the turning attempt itself, and observation afterward.^[1]

Before attempting to turn the baby, healthcare providers conduct thorough assessments. An ultrasound examination confirms the baby’s exact position, checks the location of the placenta (the organ that nourishes the baby during pregnancy), and measures the amount of amniotic fluid present. The baby’s heart rate is carefully monitored using fetal monitoring equipment to ensure the baby is tolerating the procedure well. These baseline measurements are essential because they help the medical team recognize immediately if something changes during the turning process.^[5]

The most significant advancement in making ECV more successful has been the use of tocolytic agents—medications that relax the uterine muscles. The most commonly used tocolytic is terbutaline, which belongs to a class of drugs called beta-stimulants. Studies have shown that terbutaline can double the success rate of external cephalic version. This medication is typically injected under the skin before the procedure begins. Women often notice their heart rate increasing temporarily after receiving terbutaline, which usually subsides within a few minutes and is not dangerous. Another medication sometimes used is salbutamol, administered in a similar way to relax the uterus and facilitate the baby’s movement.^[4][5]

During the actual turning procedure, the obstetrician places their hands on specific points of the mother’s abdomen. Using firm, steady pressure, they attempt to rotate the baby, either in a forward roll motion or a backward flip, depending on the baby’s position and which direction seems most favorable. The ultrasound machine remains on throughout the procedure, allowing the healthcare provider to watch the baby’s movement in real-time. Continuous monitoring of the baby’s heart rate ensures that the baby is not experiencing distress. If the baby’s heart rate becomes abnormal or the mother experiences significant discomfort, the procedure is stopped immediately.^[6]

Many women describe feeling pressure and discomfort during the procedure, comparing it to strong cramping. The sensation comes from both the external pressure being applied and the stretching of the uterus as the baby moves. Some healthcare providers offer pain medication as an option, though this is not standard practice everywhere. The procedure may need to be attempted more than once if the first attempt is unsuccessful, and some providers will schedule a second attempt at a later date if appropriate.^[1]

After the procedure, whether successful or not, the baby’s heart rate continues to be monitored for a period of time. If the baby was successfully turned, the mother may receive an injection of anti-D immunoglobulin if she has a negative blood type. This prevents potential complications related to blood type incompatibility. Women are usually advised to rest for a short time before going home, and they receive instructions about warning signs to watch for that would require immediate medical attention.^[5]

Success Rates and Factors That Influence Outcomes

The success rate of external cephalic version averages around 58 to 60 percent, meaning that slightly more than half of all attempts result in the baby being successfully turned into a head-down position. However, this rate varies considerably depending on several factors related to both the mother and the baby.^[1][2]

One of the strongest predictors of success is whether the woman has given birth before. Women who have had previous pregnancies (multiparous women) have success rates that can reach 60 to 65 percent, while women pregnant for the first time (nulliparous women) may see success rates closer to 40 to 50 percent. This difference exists because women who have given birth before typically have more relaxed abdominal and uterine muscles, allowing more room for the baby to move.^[4]

The specific breech position also matters. Babies in a frank breech position—where the legs are extended straight up with feet near the head—are generally more difficult to turn than babies in a complete breech position, where the legs are folded. Interestingly, babies lying sideways across the uterus in a transverse lie or at an angle in an oblique lie often have higher success rates for version than breech babies.^[4]

Other factors associated with successful version include adequate amniotic fluid volume, a placenta located on the back wall of the uterus rather than the front, normal maternal weight, and a baby that hasn’t yet descended deeply into the pelvis. Conversely, factors that decrease success include low amniotic fluid, a placenta on the front wall of the uterus (anterior placenta), advanced cervical dilation, and a baby whose head is already engaged low in the pelvis.^[4]

Risks and Safety Considerations

While external cephalic version is generally considered safe, it does carry some risks that must be carefully weighed against the benefits. The most common issue encountered during the procedure is changes in the baby’s heart rate. Typically, if the heart rate becomes abnormal, it stabilizes quickly once the turning attempt is stopped. This happens in a small percentage of cases and usually doesn’t result in lasting harm.^[1]

More serious complications are rare, occurring in less than 1 percent of procedures. These include placental abruption, where the placenta separates from the uterine wall prematurely; premature rupture of membranes, where the amniotic sac breaks before labor begins; preterm labor; umbilical cord complications; and in extremely rare cases, stillbirth. Because of these potential complications, the procedure is always performed where emergency cesarean delivery can be conducted immediately if needed.^[1][2]

An important consideration is that some babies who are successfully turned will spontaneously turn back to a breech position. This reversion happens more frequently when the procedure is performed earlier in pregnancy, which is why most guidelines recommend waiting until 37 weeks. Even at term, a small percentage of babies will turn back to breech after a successful version.^[4]

Certain medical conditions make external cephalic version inappropriate or unsafe. These contraindications include having more than one baby (twins, triplets, or more), placenta previa (where the placenta covers the cervix), active vaginal bleeding, certain uterine abnormalities or fibroids, very low or very high amniotic fluid levels, and any existing indication for cesarean delivery such as a previous classical cesarean incision or certain maternal health conditions like uncontrolled high blood pressure or diabetes. Women who have had a previous cesarean delivery may be candidates for ECV, but this decision requires individual assessment by the healthcare provider.^[1][3]

Ongoing Research and Clinical Practice Evolution

The practice of external cephalic version continues to evolve as researchers study ways to improve success rates and safety. While not involving new drugs in the traditional sense, clinical trials and studies are examining various aspects of the procedure to optimize outcomes. These research efforts focus on timing, technique variations, and the role of different medications or approaches.

One area of active investigation involves the optimal timing for performing ECV. While 37 weeks has become the standard recommendation, some studies have examined earlier versions. Research shows that attempting the procedure at 36 weeks or even earlier may have higher initial success rates because there is more space and amniotic fluid for the baby to move. However, these earlier attempts also carry a higher risk of preterm birth if complications occur and come with increased rates of the baby turning back to breech position before delivery. The balance between these competing factors continues to be studied.^[4]

Another focus of research involves comparing different tocolytic medications and administration methods. While terbutaline given by injection has become widely used and shows clear benefits, researchers have studied whether other types of tocolytics might be equally or more effective. Some studies have examined nitric oxide donors, medications that might relax the uterus through a different mechanism, but current evidence suggests these are less effective than beta-stimulants and their use is discouraged. The dosage and timing of tocolytic administration have also been subjects of investigation, seeking the optimal protocol that provides maximum uterine relaxation with minimum side effects.^[4]

Research has also explored the use of neuraxial anesthesia—epidural or spinal anesthesia—during external cephalic version. The hypothesis is that by providing more complete pain relief and relaxation, success rates might improve. Studies examining this approach have shown mixed results, with some suggesting modest improvements in success rates while others show no significant benefit. The added complexity, cost, and risks of neuraxial anesthesia mean that it hasn’t become standard practice, but research continues in select settings.

Clinical trials have examined performing ECV in different settings and at different points in the pregnancy journey. Some research has looked at attempting version when a woman arrives at the hospital already in early labor with a breech baby. These “ECV during labor admission” studies have shown success rates around 65 percent and are associated with lower cesarean delivery rates and shorter hospital stays. However, information remains limited about safety in women with previous uterine scars or during active labor stages, so this approach requires careful patient selection.^[4]

Researchers have also investigated various physical maneuvers and positioning strategies to enhance success. Different hand positions, directional approaches (forward roll versus backward flip), and the use of acoustic stimulation or vibroacoustic stimulation to encourage the baby to move have all been studied. While some techniques show promise in small studies, there’s no consensus yet on which specific maneuvers produce superior outcomes across all situations.

Another area of interest involves identifying women most likely to benefit from ECV through better prediction models. Studies have examined multiple factors including ultrasound measurements, maternal characteristics, and fetal position details to develop scoring systems that might predict success. If healthcare providers could more accurately identify which women have high versus low likelihood of successful version, they could better counsel patients and potentially modify approaches. However, no single prediction model has been validated widely enough for routine clinical use.

The role of repeat attempts following an unsuccessful initial ECV is also being studied. Some research suggests that offering a second attempt at a later date, particularly if factors have changed (such as increased amniotic fluid or different fetal position), can be successful in a meaningful proportion of cases. Guidelines increasingly support offering repeat attempts when appropriate, though the optimal interval between attempts and the circumstances most favorable for success remain areas of active study.

Evidence continues to accumulate regarding the cost-effectiveness of offering ECV. Economic analyses consistently show that widespread availability and use of the procedure produces significant healthcare savings by reducing cesarean deliveries. These studies examine not just the immediate costs of the procedure versus surgery, but also longer-term costs related to recovery, future pregnancies (where previous cesarean increases risks), and maternal complications. The evidence supporting ECV’s cost-effectiveness has helped drive efforts to ensure the procedure is widely available and offered to eligible women.

Despite strong evidence supporting external cephalic version, studies consistently show that between 20 and 30 percent of eligible women are not offered the procedure. Research into this “implementation gap” examines barriers to offering ECV, including provider training and confidence, institutional support and resources, and patient awareness and preferences. Efforts to increase appropriate use of ECV include educational programs for healthcare providers, quality improvement initiatives at hospitals, and better patient education materials so women can make informed decisions about their care options.

Most common treatment methods

• Tocolytic medications
  • Terbutaline injected under the skin to relax the uterus, which has been shown to double the success rate of version
  • Salbutamol administered subcutaneously as an alternative uterine relaxant
  • Beta-stimulant medications temporarily increase maternal heart rate but are safe for both mother and baby
  • Medication effect typically lasts long enough to complete the turning procedure
• Physical manipulation techniques
  • Forward roll maneuver where the baby is rotated head-over-bottom in one direction
  • Backward flip approach rotating the baby in the opposite direction
  • Selection of technique based on baby’s starting position and provider assessment of easiest path
  • Firm, controlled pressure applied to mother’s abdomen at specific points
• Ultrasound guidance
  • Continuous ultrasound monitoring throughout the procedure to visualize baby’s position
  • Pre-procedure ultrasound to assess placental location, amniotic fluid volume, and exact fetal position
  • Real-time imaging allows provider to adjust hand position and pressure during turning
• Fetal heart rate monitoring
  • Continuous electronic fetal monitoring before, during, and after the procedure
  • Immediate detection of any signs of fetal distress or abnormal heart patterns
  • Monitoring typically continues for a period after the procedure to ensure stability